Is SURI or JNJ a better dividend investment in 2026?

SURI currently yields 17.32% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SURI offers higher current income.

What is the dividend yield difference between SURI and JNJ?

SURI has a forward dividend yield of 17.32% ($2.72/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 13.96 percentage points.

Home › Compare › SURI vs JNJ

SURI vs JNJ: Dividend Comparison 2026

SURI yields 17.32% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SURI wins by $41.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SURI

● Live price

17.32%

Share price

$15.70

Annual div

$2.72

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$61.9K

Annual income

$5,009.06

Full SURI calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SURI vs JNJ

📍 SURI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SURI	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SURI + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SURI pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SURI

Annual income on $10K today (after 15% tax)

$1,472.61/yr

After 10yr DRIP, annual income (after tax)

$4,257.70/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SURI beats the other by $3,554.09/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SURI + JNJ for your $10,000?

SURI: 50%JNJ: 50%

100% JNJ50/50100% SURI

Portfolio after 10yr

$41.0K

Annual income

$2,918.42/yr

Blended yield

7.13%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SURI

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SURI buys

JNJ buys

No recent congressional trades found for SURI or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSURIJNJ

Forward yield	17.32% ✓	3.36%
Annual dividend / share	$2.72	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$61.9K ✓	$20.0K
Annual income after 10y	$5,009.06 ✓	$827.78
Total dividends collected	$32.6K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SURI vs JNJ ($10,000, DRIP)

Year	SURI Portfolio	SURI Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,432	$1,732.48	$10,676	$355.77	+$1.8K → SURI
2	$15,316	$2,013.00	$11,407	$389.39	+$3.9K → SURI
3	$18,705	$2,317.61	$12,198	$426.53	+$6.5K → SURI
4	$22,660	$2,645.37	$13,056	$467.62	+$9.6K → SURI
5	$27,241	$2,995.01	$13,987	$513.12	+$13.3K → SURI
6	$32,513	$3,364.96	$14,998	$563.56	+$17.5K → SURI
7	$38,543	$3,753.43	$16,098	$619.52	+$22.4K → SURI
8	$45,399	$4,158.38	$17,295	$681.69	+$28.1K → SURI
9	$53,155	$4,577.68	$18,599	$750.82	+$34.6K → SURI
10	$61,885	$5,009.06	$20,022	$827.78	+$41.9K → SURI

SURI vs JNJ: Complete Analysis 2026

SURI — Stock

The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.

Full SURI Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SURI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SURI vs SCHD SURI vs JEPI SURI vs O SURI vs KO SURI vs MAIN SURI vs ABBV SURI vs MRK SURI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.